Think of Etelcalcetide as an IV Alternative to Cinacalcet
You'll see a new "calcimimetic," etelcalcetide (Parsabiv, PAR-sah-biv), for treating hyperparathyroidism in dialysis patients.
This condition is a vicious cycle.
Kidney failure leads to high phosphorous...which binds calcium. Low calcium triggers parathyroid hormone release...which boosts calcium, such as by pulling it from the GI tract and bones into blood. Phosphorous keeps binding calcium...which continues to trigger parathyroid hormone release.